Lanfan Medical announced that the holding subsidiary Lanfan Baisheng plans to continue to introduce the A2 round strategic investor Daxing Rinkong Development Fund to increase capital and shares. This time, the investors plan to increase the total capital amount to Lanfan Baisheng in cash according to a pre-investment valuation of 4.9 billion yuan, and subscribe to Lanfan Basheng to add a registered capital of 25482.79 million yuan, corresponding to 2% of Lanfan Baisheng's total shares after this transaction.
蓝帆医疗：子公司拟继续引入大兴临空发展基金进行增资扩股
Lanfan Healthcare: The subsidiary plans to continue to introduce Daxing Rinkong Development Fund to increase capital and expand shares
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.